+ Watch MRK
on My Watchlist
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
Long-term outperform for a steady Eddie in a strong industry.- Incredibly strong drug pipeline- Josh Brown's top Dow selection for the next 17 years. (cicada reference)- 3.6% dividend- Broad demographic shift towards more demand for their goods- Somewhat expensive, but justified, as it is a great defensive selection5+ year outperform as Merck looks to reinvigorate its sales with 6 quality drugs in its pipeline.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions